benign prostate hypertrophy

Updated: July 4, 2024

Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

prazosin

off-label
Initial:

0.5

Orally

every 12 hrs

Maintenance: 2 mg orally 12 hours

doxazosin

Immediate release: 1 mg orally once a day; the dose can be titrated to double the dose up to 8 mg
ER: 4 mg orally per day; can be titrated based on response every 3-4 weeks to 8 mg orally once a day

terazosin

Initial:

Orally

once a day

Dose can increase up to 5 mg- 20 mg orally once a day

Dose Adjustments

Dosing considerations:
To prevent syncope first dose and subsequent dose preferred at bedtime and can be taken with food

tamsulosin

Indicated to treat the symptoms of BPH (benign prostatic hyperplasia)
0.4 mg orally each day; take the dose half an hour after the meals
After 2-4 weeks of inadequate response, increase the dose to 0.8 mg each day
If therapy is suspended for many days, start the dose at 0.4 mg each day and increase if required

Future Trends